User Tools

Site Tools


anticoagulation_resumption_after_intracranial_hemorrhage

Anticoagulation Resumption after intracranial hemorrhage

Only randomized controlled trials, either pragmatic or explanatory, can provide more conclusive answers for this important clinical question 1).

In 2018, a systematic review and meta-analysis showed that resuming anticoagulant therapy after interruption for anticoagulation-associated intracranial hemorrhage reduced the risks of thromboembolic events, without significantly increasing the risks of ICH recurrence and long-term mortality 2).

see Anticoagulation Resumption after chronic subdural hematoma.

see Anticoagulation Resumption after intracerebral hemorrhage.

see Anticoagulation Resumption after traumatic brain injury.

1)
Hawkes MA, Rabinstein AA. Anticoagulation for atrial fibrillation after intracranial hemorrhage: A systematic review. Neurol Clin Pract. 2018 Feb;8(1):48-57. doi: 10.1212/CPJ.0000000000000425. Review. PubMed PMID: 29517050; PubMed Central PMCID: PMC5839688.
2)
Zhou Z, Yu J, Carcel C, Delcourt C, Shan J, Lindley RI, Neal B, Anderson CS, Hackett ML. Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis. BMJ Open. 2018 May 14;8(5):e019672. doi: 10.1136/bmjopen-2017-019672. PubMed PMID: 29764874; PubMed Central PMCID: PMC5961574.
anticoagulation_resumption_after_intracranial_hemorrhage.txt · Last modified: 2018/11/21 22:32 by administrador